@article{oldfield_experiences_2022,
	title = {Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of {New} {Zealand} doctors in an oncology setting},
	volume = {98},
	issn = {1469-0756},
	doi = {10.1136/postgradmedj-2020-139013},
	abstract = {PURPOSE OF STUDY: To explore the experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in New Zealand doctors in an oncology setting.
STUDY DESIGN: An observational cross-sectional survey undertaken between November 2019 and January 2020 across four secondary-care hospital oncology departments within New Zealand (Auckland, Wellington, Christchurch and Dunedin). Participants were a convenience sample of doctors; consultants, registrars, medical officers of special status and house surgeons working in oncology departments. Of 53 individuals approached, 45 participated (85\% Response Rate). The primary outcome was reporteddoctor-patient interactions. Secondary outcomes included knowledge of cannabis-based products, their efficacy, prescribing regulations and educational access.
RESULTS: Of 44 doctors, 37 (84\%, 95\% CI: 70 to 93) reported patient requests to prescribe cannabis-based products and 43 (98\%, 95\% CI: 88 to 100) reported patients using illicit cannabis for medical symptoms. Primary request reasons were pain, nausea/vomiting and cancer treatment. 33/45 (73\%, 95\% CI: 58 to 85) cited knowledge of at least one cannabis-based product and 27/45 (60\%, 95\% CI: 44 to 74) indicated at least one condition that had evidence of efficacy. 36/44 (82\%, 95\% CI: 67 to 92) expressed future prescribing concerns but all were willing to use a cannabis-based product developed with traditional medical provenance.
CONCLUSION: In the oncology setting, patients are asking doctors about symptomatic and curative treatment with cannabis-based products. Doctors are not biased against the use of products showing medical provenance; however, NZ-specific clinical and regulatory guidelines are essential to support patient discussions and appropriate prescribing.},
	language = {eng},
	number = {1155},
	journal = {Postgraduate Medical Journal},
	author = {Oldfield, Karen and Eathorne, Allie and Tewhaiti-Smith, Jordan and Beasley, Richard and Semprini, Alex and Braithwaite, Irene},
	month = jan,
	year = {2022},
	pmid = {33218966},
	keywords = {Adult, Aged, Attitude of Health Personnel, Cannabis, Cross-Sectional Studies, Female, Health Knowledge, Attitudes, Practice, Humans, Male, Medical Marijuana, Medicine, Middle Aged, Neoplasms, New Zealand, Oncology, Physician-Patient Relations, Physicians, chemotherapy, complementary medicine, education \& training (see medical education \& training), pain management},
	pages = {35--42},
}

{"_id":"2TwHtX9ARj4tAZGeX","bibbaseid":"oldfield-eathorne-tewhaitismith-beasley-semprini-braithwaite-experiencespatientinteractionsandknowledgeregardingtheuseofcannabisasamedicineinacohortofnewzealanddoctorsinanoncologysetting-2022","author_short":["Oldfield, K.","Eathorne, A.","Tewhaiti-Smith, J.","Beasley, R.","Semprini, A.","Braithwaite, I."],"bibdata":{"bibtype":"article","type":"article","title":"Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of New Zealand doctors in an oncology setting","volume":"98","issn":"1469-0756","doi":"10.1136/postgradmedj-2020-139013","abstract":"PURPOSE OF STUDY: To explore the experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in New Zealand doctors in an oncology setting. STUDY DESIGN: An observational cross-sectional survey undertaken between November 2019 and January 2020 across four secondary-care hospital oncology departments within New Zealand (Auckland, Wellington, Christchurch and Dunedin). Participants were a convenience sample of doctors; consultants, registrars, medical officers of special status and house surgeons working in oncology departments. Of 53 individuals approached, 45 participated (85% Response Rate). The primary outcome was reporteddoctor-patient interactions. Secondary outcomes included knowledge of cannabis-based products, their efficacy, prescribing regulations and educational access. RESULTS: Of 44 doctors, 37 (84%, 95% CI: 70 to 93) reported patient requests to prescribe cannabis-based products and 43 (98%, 95% CI: 88 to 100) reported patients using illicit cannabis for medical symptoms. Primary request reasons were pain, nausea/vomiting and cancer treatment. 33/45 (73%, 95% CI: 58 to 85) cited knowledge of at least one cannabis-based product and 27/45 (60%, 95% CI: 44 to 74) indicated at least one condition that had evidence of efficacy. 36/44 (82%, 95% CI: 67 to 92) expressed future prescribing concerns but all were willing to use a cannabis-based product developed with traditional medical provenance. CONCLUSION: In the oncology setting, patients are asking doctors about symptomatic and curative treatment with cannabis-based products. Doctors are not biased against the use of products showing medical provenance; however, NZ-specific clinical and regulatory guidelines are essential to support patient discussions and appropriate prescribing.","language":"eng","number":"1155","journal":"Postgraduate Medical Journal","author":[{"propositions":[],"lastnames":["Oldfield"],"firstnames":["Karen"],"suffixes":[]},{"propositions":[],"lastnames":["Eathorne"],"firstnames":["Allie"],"suffixes":[]},{"propositions":[],"lastnames":["Tewhaiti-Smith"],"firstnames":["Jordan"],"suffixes":[]},{"propositions":[],"lastnames":["Beasley"],"firstnames":["Richard"],"suffixes":[]},{"propositions":[],"lastnames":["Semprini"],"firstnames":["Alex"],"suffixes":[]},{"propositions":[],"lastnames":["Braithwaite"],"firstnames":["Irene"],"suffixes":[]}],"month":"January","year":"2022","pmid":"33218966","keywords":"Adult, Aged, Attitude of Health Personnel, Cannabis, Cross-Sectional Studies, Female, Health Knowledge, Attitudes, Practice, Humans, Male, Medical Marijuana, Medicine, Middle Aged, Neoplasms, New Zealand, Oncology, Physician-Patient Relations, Physicians, chemotherapy, complementary medicine, education & training (see medical education & training), pain management","pages":"35–42","bibtex":"@article{oldfield_experiences_2022,\n\ttitle = {Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of {New} {Zealand} doctors in an oncology setting},\n\tvolume = {98},\n\tissn = {1469-0756},\n\tdoi = {10.1136/postgradmedj-2020-139013},\n\tabstract = {PURPOSE OF STUDY: To explore the experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in New Zealand doctors in an oncology setting.\nSTUDY DESIGN: An observational cross-sectional survey undertaken between November 2019 and January 2020 across four secondary-care hospital oncology departments within New Zealand (Auckland, Wellington, Christchurch and Dunedin). Participants were a convenience sample of doctors; consultants, registrars, medical officers of special status and house surgeons working in oncology departments. Of 53 individuals approached, 45 participated (85\\% Response Rate). The primary outcome was reporteddoctor-patient interactions. Secondary outcomes included knowledge of cannabis-based products, their efficacy, prescribing regulations and educational access.\nRESULTS: Of 44 doctors, 37 (84\\%, 95\\% CI: 70 to 93) reported patient requests to prescribe cannabis-based products and 43 (98\\%, 95\\% CI: 88 to 100) reported patients using illicit cannabis for medical symptoms. Primary request reasons were pain, nausea/vomiting and cancer treatment. 33/45 (73\\%, 95\\% CI: 58 to 85) cited knowledge of at least one cannabis-based product and 27/45 (60\\%, 95\\% CI: 44 to 74) indicated at least one condition that had evidence of efficacy. 36/44 (82\\%, 95\\% CI: 67 to 92) expressed future prescribing concerns but all were willing to use a cannabis-based product developed with traditional medical provenance.\nCONCLUSION: In the oncology setting, patients are asking doctors about symptomatic and curative treatment with cannabis-based products. Doctors are not biased against the use of products showing medical provenance; however, NZ-specific clinical and regulatory guidelines are essential to support patient discussions and appropriate prescribing.},\n\tlanguage = {eng},\n\tnumber = {1155},\n\tjournal = {Postgraduate Medical Journal},\n\tauthor = {Oldfield, Karen and Eathorne, Allie and Tewhaiti-Smith, Jordan and Beasley, Richard and Semprini, Alex and Braithwaite, Irene},\n\tmonth = jan,\n\tyear = {2022},\n\tpmid = {33218966},\n\tkeywords = {Adult, Aged, Attitude of Health Personnel, Cannabis, Cross-Sectional Studies, Female, Health Knowledge, Attitudes, Practice, Humans, Male, Medical Marijuana, Medicine, Middle Aged, Neoplasms, New Zealand, Oncology, Physician-Patient Relations, Physicians, chemotherapy, complementary medicine, education \\& training (see medical education \\& training), pain management},\n\tpages = {35--42},\n}\n\n","author_short":["Oldfield, K.","Eathorne, A.","Tewhaiti-Smith, J.","Beasley, R.","Semprini, A.","Braithwaite, I."],"key":"oldfield_experiences_2022","id":"oldfield_experiences_2022","bibbaseid":"oldfield-eathorne-tewhaitismith-beasley-semprini-braithwaite-experiencespatientinteractionsandknowledgeregardingtheuseofcannabisasamedicineinacohortofnewzealanddoctorsinanoncologysetting-2022","role":"author","urls":{},"keyword":["Adult","Aged","Attitude of Health Personnel","Cannabis","Cross-Sectional Studies","Female","Health Knowledge","Attitudes","Practice","Humans","Male","Medical Marijuana","Medicine","Middle Aged","Neoplasms","New Zealand","Oncology","Physician-Patient Relations","Physicians","chemotherapy","complementary medicine","education & training (see medical education & training)","pain management"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/6607533/collections/VKGURBGN/items?key=hSjrOPQRRHHWY81SKs6CEz45&format=bibtex&limit=100","dataSources":["upP78A3qvEd6tbHFm","zpWcq5jS35za3AmLx"],"keywords":["adult","aged","attitude of health personnel","cannabis","cross-sectional studies","female","health knowledge","attitudes","practice","humans","male","medical marijuana","medicine","middle aged","neoplasms","new zealand","oncology","physician-patient relations","physicians","chemotherapy","complementary medicine","education & training (see medical education & training)","pain management"],"search_terms":["experiences","patient","interactions","knowledge","regarding","use","cannabis","medicine","cohort","new","zealand","doctors","oncology","setting","oldfield","eathorne","tewhaiti-smith","beasley","semprini","braithwaite"],"title":"Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of New Zealand doctors in an oncology setting","year":2022}